GSA Capital Partners’s ImmunityBio IBRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$435K	Buy	56,660 +40,700	+255%	+$279K	0.03%	1002
2025 Q4	$32K	Buy	+15,960	New	+$36.2K	﹤0.01%	1590
2025 Q1	–	Sell	-41,031	Closed	-$105K	–	1837
2024 Q4	$105K	Sell	41,031 -66,954	-62%	-$279K	0.01%	1509
2024 Q3	$402K	Buy	107,985 +80,318	+290%	+$372K	0.03%	1058
2024 Q2	$175K	Buy	+27,667	New	+$182K	0.01%	1477
2023 Q1	–	Sell	-22,043	Closed	-$112K	–	1678
2022 Q4	$112K	Buy	+22,043	New	+$121K	0.01%	1291
2022 Q3	–	Sell	-84,884	Closed	-$316K	–	1682
2022 Q2	$316K	Buy	84,884 +1,680	+2%	+$6.75K	0.05%	789
2022 Q1	$467K	Sell	83,204 -46,056	-36%	-$283K	0.06%	583
2021 Q4	$786K	Buy	+129,260	New	+$971K	0.1%	323
2020 Q2	–	Sell	-13,119	Closed	-$38K	–	841
2020 Q1	$38K	Buy	+13,119	New	+$65.7K	0.01%	969